Operating
Stock-Based Comp
AbbVie Stock-Based Comp decreased by 24.9% to $157.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.3%, from $164.00M to $157.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 8.4% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Detailed definition
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
Peer comparison
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
Metric ID:
cf_stock_based_compensationHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $159.00M | $135.00M | $129.00M | $306.00M | $107.00M | $126.00M | $132.00M | $313.00M | $179.00M | $130.00M | $125.00M | $348.00M | $218.00M | $181.00M | $164.00M | $410.00M | $179.00M | $209.00M | $157.00M |
| QoQ Change | — | -15.1% | -4.4% | +137.2% | -65.0% | +17.8% | +4.8% | +137.1% | -42.8% | -27.4% | -3.8% | +178.4% | -37.4% | -17.0% | -9.4% | +150.0% | -56.3% | +16.8% | -24.9% |
| YoY Change | — | — | — | — | -32.7% | -6.7% | +2.3% | +2.3% | +67.3% | +3.2% | -5.3% | +11.2% | +21.8% | +39.2% | +31.2% | +17.8% | -17.9% | +15.5% | -4.3% |
Range$107.00M – $410.00M
CAGR-0.3%
Avg YoY Growth+9.7%
Median YoY Growth+3.2%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is AbbVie's stock-based comp?
- AbbVie (ABBV) reported stock-based comp of $157.00M in Q4 2025.
- How has AbbVie's stock-based comp changed year-over-year?
- AbbVie's stock-based comp decreased by 4.3% year-over-year, from $164.00M to $157.00M.
- What is the long-term trend for AbbVie's stock-based comp?
- Over 4 years (2021 to 2025), AbbVie's stock-based comp has grown at a 8.4% compound annual growth rate (CAGR), from $692.00M to $955.00M.
- What does stock-based comp mean?
- The value of company shares given to employees as part of their pay.